Reconstituted HDL elicits marked changes in plasma lipids following single-dose injection in C57Bl/6 mice (Q39446360)

12 September 2017

Reconstituted HDL elicits marked changes in plasma lipids following single-dose injection in C57Bl/6 mice (English)

1 reference

12 September 2017

10

Alison M Strack

1 reference

12 September 2017

Zhu Chen

1

1 reference

12 September 2017

Edward A O'Neill

2

1 reference

12 September 2017

Roger D Meurer

3

1 reference

12 September 2017

Karen Gagen

4

1 reference

12 September 2017

Silvi Luell

5

1 reference

12 September 2017

Sheng-Ping Wang

6

1 reference

12 September 2017

Marina Ichetovkin

7

1 reference

12 September 2017

Betsy Frantz-Wattley

8

1 reference

12 September 2017

Suzanne Eveland

9

1 reference

12 September 2017

Timothy S Fisher

11

1 reference

12 September 2017

Douglas G Johns

12

1 reference

12 September 2017

Carl P Sparrow

13

1 reference

12 September 2017

Samuel D Wright

14

1 reference

12 September 2017

Brian K Hubbard

15

1 reference

12 September 2017

Ester Carballo-Jane

16

1 reference

12 September 2017

8 November 2011

1 reference

Journal of Cardiovascular Pharmacology and Therapeutics

12 September 2017

1 reference

12 September 2017

17

1 reference

12 September 2017

315-323

1 reference

12 September 2017

3

1 reference

High density lipoproteins and coronary heart disease

12 September 2017

1 reference

https://api.crossref.org/works/10.1177%2F1074248411426144

Effects of niacin on atherosclerosis and vascular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411426144

Cholesteryl ester transfer protein inhibitor torcetrapib and off-target toxicity: a pooled analysis of the rating atherosclerotic disease change by imaging with a new CETP inhibitor (RADIANCE) trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411426144

RVX-208: a small molecule that increases apolipoprotein A-I and high-density lipoprotein cholesterol in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411426144

An apoA-I mimetic peptide containing a proline residue has greater in vivo HDL binding and anti-inflammatory ability than the 4F peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411426144

Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411426144

A novel method for oral delivery of apolipoprotein mimetic peptides synthesized from all L-amino acids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411426144

Structure and function of HDL mimetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411426144

ApoA-I mimetic peptides promote pre-β HDL formation in vivo causing remodeling of HDL and triglyceride accumulation at higher dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411426144

Acute effects of intravenous infusion of ApoA1/phosphatidylcholine discs on plasma lipoproteins in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411426144

Reconstituted high-density lipoprotein increases plasma high-density lipoprotein anti-inflammatory properties and cholesterol efflux capacity in patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411426144

Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411426144

Infusion of reconstituted high-density lipoprotein leads to acute changes in human atherosclerotic plaque.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411426144

A reconstituted HDL containing V156K or R173C apoA-I exhibited anti-inflammatory activity in apo-E deficient mice and showed resistance to myeloperoxidase-mediated oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411426144

Efficacy and safety of a novel oral inducer of apolipoprotein a-I synthesis in statin-treated patients with stable coronary artery disease a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411426144

Lipoprotein inflammatory properties and serum amyloid A levels but not cholesterol levels predict lesion area in cholesterol-fed rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411426144

Treatment of patients with cardiovascular disease with L-4F, an apo-A1 mimetic, did not improve select biomarkers of HDL function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411426144

Stimulation of fecal steroid excretion after infusion of recombinant proapolipoprotein A-I. Potential reverse cholesterol transport in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411426144

Effect of up-regulating individual steps in the reverse cholesterol transport pathway on reverse cholesterol transport in normolipidemic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411426144

Effects of intravenous apolipoprotein A-I/phosphatidylcholine discs on LCAT, PLTP, and CETP in plasma and peripheral lymph in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411426144

Reconstituted HDL infusion restores endothelial function in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411426144

Differential effects of HDL subpopulations on cellular ABCA1- and SR-BI-mediated cholesterol efflux

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411426144

Characterization and properties of pre beta-HDL particles formed by ABCA1-mediated cellular lipid efflux to apoA-I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411426144

In vivo modulation of HDL phospholipid has opposing effects on SR-BI- and ABCA1-mediated cholesterol efflux

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411426144

Expression of human lecithin-cholesterol acyltransferase in transgenic mice. Effect of human apolipoprotein AI and human apolipoprotein all on plasma lipoprotein cholesterol metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411426144

Comparative specificity of plasma lecithin:cholesterol acyltransferase from ten animal species.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411426144

21 January 2018

Identifiers

DOI

10.1177/1074248411426144

1 reference

12 September 2017

1 reference